MA24833A1 - Procede pour alkyler des sulfonamides a encombrement sterique - Google Patents

Procede pour alkyler des sulfonamides a encombrement sterique

Info

Publication number: MA24833A1
Authority: MA; Morocco
Prior art keywords: alkyling; sulfonamides; sterically; bulk; sterically bulk
Prior art date: 1998-04-10

Application number

MA25530A

Other languages

English (en)

Inventor

Michael Hawkins Joel

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-10

Filing date

1999-04-07

Publication date

1999-12-31

1999-04-07 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-12-31 Publication of MA24833A1 publication Critical patent/MA24833A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Virology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)

MA25530A 1998-04-10 1999-04-07 Procede pour alkyler des sulfonamides a encombrement sterique MA24833A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8131098P	1998-04-10	1998-04-10

Publications (1)

Publication Number	Publication Date
MA24833A1 true MA24833A1 (fr)	1999-12-31

Family

ID=22163376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25530A MA24833A1 (fr)	1998-04-10	1999-04-07	Procede pour alkyler des sulfonamides a encombrement sterique

Country Status (47)

Country	Link
US (2)	US6114568A (fr)
EP (2)	EP0949245B1 (fr)
JP (2)	JP3479511B2 (fr)
KR (2)	KR100357660B1 (fr)
CN (3)	CN1296474A (fr)
AP (1)	AP1095A (fr)
AR (1)	AR017731A1 (fr)
AT (2)	ATE206392T1 (fr)
AU (2)	AU755004B2 (fr)
BG (1)	BG63665B1 (fr)
BR (2)	BR9902219A (fr)
CA (2)	CA2268684C (fr)
CO (1)	CO4810299A1 (fr)
DE (2)	DE69900321T2 (fr)
DK (1)	DK0949245T3 (fr)
DZ (1)	DZ2754A1 (fr)
EA (1)	EA002277B1 (fr)
EG (1)	EG21985A (fr)
ES (2)	ES2163316T3 (fr)
GT (1)	GT199900047A (fr)
HN (1)	HN1999000043A (fr)
HR (1)	HRP990106B1 (fr)
HU (2)	HUP0101465A3 (fr)
ID (2)	ID23244A (fr)
IL (2)	IL129168A (fr)
IN (1)	IN192485B (fr)
IS (1)	IS5018A (fr)
MA (1)	MA24833A1 (fr)
NO (1)	NO991675L (fr)
NZ (1)	NZ335105A (fr)
OA (1)	OA11030A (fr)
PA (1)	PA8469601A1 (fr)
PE (1)	PE20000417A1 (fr)
PL (2)	PL332451A1 (fr)
PT (1)	PT949245E (fr)
RU (1)	RU2197479C2 (fr)
SA (1)	SA99200089A (fr)
SG (1)	SG75167A1 (fr)
SK (1)	SK45399A3 (fr)
TN (1)	TNSN99054A1 (fr)
TR (2)	TR199900756A2 (fr)
TW (1)	TW520354B (fr)
UA (1)	UA57039C2 (fr)
UY (1)	UY25469A1 (fr)
WO (1)	WO1999052862A1 (fr)
YU (1)	YU18399A (fr)
ZA (2)	ZA992627B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458822B2 (en)	2000-03-13	2002-10-01	Pfizer Inc.	2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
EP1134207A1 (fr) *	2000-03-15	2001-09-19	Pfizer Products Inc.	Procédé pour la préparation de dérivés du résorcinol
WO2001077092A1 (fr) *	2000-04-07	2001-10-18	Samsung Electronics Co., Ltd.	Derive sulfonamide utilise en tant qu'inhibiteur de metalloproteinase matricielle
US20020073441A1 (en)	2000-12-13	2002-06-13	Ross Brian D.	Compositions and methods for detecting proteolytic activity
US6844373B2 (en) *	2002-05-28	2005-01-18	Alcatel	Composition comprising fluorinated, radiation-curable dyes for surface energy control
ATE457716T1 (de)	2002-12-30	2010-03-15	Angiotech Int Ag	Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
ITFI20040174A1 (it) *	2004-08-03	2004-11-03	Protera S R L	Derivati arilsolfonammidici dell'acido idrossammico ad azione inibitoria di metalloproteinasi
ITBO20050005U1 (it) *	2005-01-31	2006-08-01	Ali Spa	Distributore di bevande ghiacciate e simili

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA794723B (en)	1978-09-11	1980-08-27	Univ Miami	Anti-hypertensive agents
GB9000725D0 (en)	1990-01-12	1990-03-14	Pfizer Ltd	Therapeutic agents
US5506242A (en)	1993-01-06	1996-04-09	Ciba-Geigy Corporation	Arylsufonamido-substituted hydroxamic acids
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
EP0922030A1 (fr) *	1996-08-23	1999-06-16	Pfizer Inc.	Derives de l'acide arylsulfonylamino hydroxamique
ATE248812T1 (de)	1997-02-03	2003-09-15	Pfizer Prod Inc	Arylsulfonylhydroxamsäurederivate
JP3448275B2 (ja)	1997-08-08	2003-09-22	ファイザー・プロダクツ・インク	アリールオキシアリールスルホニルアミノヒドロキサム酸誘導体
EP0895988B1 (fr)	1997-08-08	2002-05-22	Pfizer Products Inc.	Dérivés de l'acide arylsulfonamino-hydroxamique
PA8469401A1 (es)	1998-04-10	2000-05-24	Pfizer Prod Inc	Derivados biciclicos del acido hidroxamico

1999
- 1999-03-24 PA PA19998469601A patent/PA8469601A1/es unknown
- 1999-03-25 DE DE69900321T patent/DE69900321T2/de not_active Expired - Fee Related
- 1999-03-25 PT PT99302287T patent/PT949245E/pt unknown
- 1999-03-25 IL IL12916899A patent/IL129168A/xx not_active IP Right Cessation
- 1999-03-25 DK DK99302287T patent/DK0949245T3/da active
- 1999-03-25 AT AT99302287T patent/ATE206392T1/de not_active IP Right Cessation
- 1999-03-25 ES ES99302287T patent/ES2163316T3/es not_active Expired - Lifetime
- 1999-03-25 GT GT199900047A patent/GT199900047A/es unknown
- 1999-03-25 EP EP99302287A patent/EP0949245B1/fr not_active Expired - Lifetime
- 1999-04-01 OA OA9900073A patent/OA11030A/en unknown
- 1999-04-05 ID IDP990304D patent/ID23244A/id unknown
- 1999-04-06 IS IS5018A patent/IS5018A/is unknown
- 1999-04-06 PE PE1999000277A patent/PE20000417A1/es not_active Application Discontinuation
- 1999-04-07 TW TW088105541A patent/TW520354B/zh not_active IP Right Cessation
- 1999-04-07 MA MA25530A patent/MA24833A1/fr unknown
- 1999-04-07 TN TNTNSN99054A patent/TNSN99054A1/fr unknown
- 1999-04-07 SK SK453-99A patent/SK45399A3/sk unknown
- 1999-04-07 KR KR1019990011957A patent/KR100357660B1/ko not_active IP Right Cessation
- 1999-04-07 DZ DZ990055A patent/DZ2754A1/fr active
- 1999-04-07 IN IN522DE1999 patent/IN192485B/en unknown
- 1999-04-08 AR ARP990101601A patent/AR017731A1/es active IP Right Grant
- 1999-04-08 EG EG37499A patent/EG21985A/xx active
- 1999-04-08 CA CA002268684A patent/CA2268684C/fr not_active Expired - Fee Related
- 1999-04-08 SG SG1999001651A patent/SG75167A1/en unknown
- 1999-04-08 YU YU18399A patent/YU18399A/sh unknown
- 1999-04-08 AP APAP/P/1999/001506A patent/AP1095A/en active
- 1999-04-08 TR TR1999/00756A patent/TR199900756A2/xx unknown
- 1999-04-09 PL PL99332451A patent/PL332451A1/xx unknown
- 1999-04-09 AT AT99917394T patent/ATE284864T1/de not_active IP Right Cessation
- 1999-04-09 CA CA002327498A patent/CA2327498C/fr not_active Expired - Fee Related
- 1999-04-09 HR HR990106A patent/HRP990106B1/xx not_active IP Right Cessation
- 1999-04-09 EP EP99917394A patent/EP1068180B1/fr not_active Expired - Lifetime
- 1999-04-09 HU HU0101465A patent/HUP0101465A3/hu unknown
- 1999-04-09 TR TR2000/02950T patent/TR200002950T2/xx unknown
- 1999-04-09 NZ NZ335105A patent/NZ335105A/xx unknown
- 1999-04-09 US US09/289,454 patent/US6114568A/en not_active Expired - Fee Related
- 1999-04-09 JP JP2000543425A patent/JP3479511B2/ja not_active Expired - Fee Related
- 1999-04-09 HN HN1999000043A patent/HN1999000043A/es unknown
- 1999-04-09 US US09/290,022 patent/US6229025B1/en not_active Expired - Fee Related
- 1999-04-09 BR BR9902219-2A patent/BR9902219A/pt not_active IP Right Cessation
- 1999-04-09 KR KR10-2000-7011232A patent/KR100377718B1/ko not_active IP Right Cessation
- 1999-04-09 IL IL13877899A patent/IL138778A0/xx unknown
- 1999-04-09 AU AU23691/99A patent/AU755004B2/en not_active Ceased
- 1999-04-09 HU HU9901043A patent/HUP9901043A1/hu unknown
- 1999-04-09 WO PCT/US1999/007858 patent/WO1999052862A1/fr active IP Right Grant
- 1999-04-09 PL PL99343530A patent/PL343530A1/xx unknown
- 1999-04-09 EA EA199900277A patent/EA002277B1/ru not_active IP Right Cessation
- 1999-04-09 DE DE69922638T patent/DE69922638T2/de not_active Expired - Fee Related
- 1999-04-09 AU AU35527/99A patent/AU760213B2/en not_active Ceased
- 1999-04-09 ID IDW20002031A patent/ID27208A/id unknown
- 1999-04-09 BR BR9910110-6A patent/BR9910110A/pt not_active IP Right Cessation
- 1999-04-09 RU RU2000125555/04A patent/RU2197479C2/ru not_active IP Right Cessation
- 1999-04-09 CN CN99804961A patent/CN1296474A/zh active Pending
- 1999-04-09 ZA ZA9902627A patent/ZA992627B/xx unknown
- 1999-04-09 NO NO991675A patent/NO991675L/no not_active Application Discontinuation
- 1999-04-09 BG BG103320A patent/BG63665B1/bg unknown
- 1999-04-09 UA UA99042034A patent/UA57039C2/uk unknown
- 1999-04-09 ES ES99917394T patent/ES2234253T3/es not_active Expired - Lifetime
- 1999-04-09 CN CN99104932A patent/CN1234396A/zh active Pending
- 1999-04-12 UY UY25469A patent/UY25469A1/es unknown
- 1999-04-12 JP JP10387399A patent/JP3540959B2/ja not_active Expired - Fee Related
- 1999-04-12 CO CO99021411A patent/CO4810299A1/es unknown
- 1999-05-05 SA SA99200089A patent/SA99200089A/ar unknown
2000
- 2000-08-25 CN CN00126476A patent/CN1288885A/zh active Pending
- 2000-10-02 ZA ZA200005370A patent/ZA200005370B/en unknown

Also Published As

Publication number	Publication date
EA002277B1 (ru)	2002-02-28
SG75167A1 (en)	2000-09-19
AU755004B2 (en)	2002-11-28
HU9901043D0 (en)	1999-06-28
IL129168A0 (en)	2000-02-17
HRP990106B1 (en)	2003-08-31
BR9902219A (pt)	2000-04-11
NO991675D0 (no)	1999-04-09
CN1296474A (zh)	2001-05-23
IL138778A0 (en)	2001-10-31
AU760213B2 (en)	2003-05-08
UY25469A1 (es)	1999-11-17
IN192485B (fr)	2004-04-24
HUP9901043A1 (hu)	2000-08-28
KR19990082986A (ko)	1999-11-25
TNSN99054A1 (fr)	2005-11-10
ID27208A (id)	2001-03-08
JP2000026400A (ja)	2000-01-25
KR100357660B1 (ko)	2002-10-25
EP1068180B1 (fr)	2004-12-15
HRP990106A2 (en)	1999-12-31
CN1234396A (zh)	1999-11-10
ID23244A (id)	2000-03-30
CA2327498A1 (fr)	1999-10-21
DE69900321D1 (de)	2001-11-08
JP3479511B2 (ja)	2003-12-15
JP2002511447A (ja)	2002-04-16
ATE284864T1 (de)	2005-01-15
PT949245E (pt)	2002-02-28
HN1999000043A (es)	1999-11-03
EG21985A (en)	2002-05-31
JP3540959B2 (ja)	2004-07-07
PL343530A1 (en)	2001-08-27
TR200002950T2 (tr)	2000-12-21
BR9910110A (pt)	2001-10-09
AR017731A1 (es)	2001-09-12
ZA200005370B (en)	2002-01-03
ATE206392T1 (de)	2001-10-15
CO4810299A1 (es)	1999-06-30
OA11030A (en)	2002-02-07
EP0949245A1 (fr)	1999-10-13
AU3552799A (en)	1999-11-01
EA199900277A3 (ru)	2000-04-24
SA99200089A (ar)	2005-12-03
KR100377718B1 (ko)	2003-03-26
RU2197479C2 (ru)	2003-01-27
EP0949245B1 (fr)	2001-10-04
NO991675L (no)	1999-10-11
UA57039C2 (uk)	2003-06-16
HUP0101465A2 (hu)	2002-03-28
DE69922638T2 (de)	2005-05-19
US6229025B1 (en)	2001-05-08
BG103320A (en)	2001-08-31
CA2268684A1 (fr)	1999-10-10
DE69922638D1 (de)	2005-01-20
CA2327498C (fr)	2006-01-31
PA8469601A1 (es)	2000-09-29
ZA992627B (en)	2000-10-09
AU2369199A (en)	1999-10-21
EA199900277A2 (ru)	1999-10-28
AP9901506A0 (en)	1999-06-30
ES2234253T3 (es)	2005-06-16
KR20010042567A (ko)	2001-05-25
CA2268684C (fr)	2004-07-13
DE69900321T2 (de)	2002-07-11
TW520354B (en)	2003-02-11
BG63665B1 (bg)	2002-08-30
NZ335105A (en)	2000-03-27
TR199900756A2 (xx)	1999-11-22
HUP0101465A3 (en)	2002-11-28
EP1068180A1 (fr)	2001-01-17
IL129168A (en)	2003-07-06
CN1288885A (zh)	2001-03-28
GT199900047A (es)	2000-09-15
IS5018A (is)	1999-10-11
YU18399A (sh)	2002-11-15
AP1095A (en)	2002-08-26
SK45399A3 (en)	2000-08-14
PE20000417A1 (es)	2000-05-24
WO1999052862A1 (fr)	1999-10-21
DZ2754A1 (fr)	2003-09-15
DK0949245T3 (da)	2002-01-28
US6114568A (en)	2000-09-05
PL332451A1 (en)	1999-10-11
ES2163316T3 (es)	2002-01-16

Publication	Publication Date	Title
DE59902056D1 (de)	2002-08-22	Vorrichtung zum entleeren von sendungsbehältern
FR2721823B1 (fr)	1996-08-02	Procede pour la deformation permanente des matieres keratiniques
FR2770534B1 (fr)	2000-10-13	Procede pour enlever des graffitis
DE69909808D1 (de)	2003-08-28	Vorrichtung zum entleeren von behältern
MA24833A1 (fr)	1999-12-31	Procede pour alkyler des sulfonamides a encombrement sterique
NO20013466L (no)	2001-09-06	Fremgangsmate for a produsere en metan-rik voske
FR2793485B1 (fr)	2010-12-24	Mecanisme a couvercles pour machine a section individuelles
DE69910479D1 (de)	2003-09-25	System zum Zuführen von Bögen
FR2776226B1 (fr)	2000-06-16	Machine et procede pour reduire les pneumatiques usages en petits elements
FR2776674B1 (fr)	2002-03-29	Procede pour faire croitre un monocristal
DE59912417D1 (de)	2005-09-22	Fördervorrichtung zum Transportieren von Behältern
FR2813392B1 (fr)	2002-12-06	Procede de revelation structurale pour superalliages monocristallins
FR2795672B1 (fr)	2001-09-14	Procede de moulage pour realiser une piece a structure multicouche
FR2758742B1 (fr)	1999-04-23	Adoucisseur a encombrement reduit pour machine electro-domestique
FR2800376B1 (fr)	2003-04-18	Procede pour la production d'alkylhalogenosilanes
FR2795046B1 (fr)	2001-09-07	Procede de conditionnement d'objet a l'aide de feuilles thermo-plastiques
EP1192243A4 (fr)	2003-05-28	Procede destine a promouvoir l'hematopoiese
FR2725967B1 (fr)	1996-12-20	Procede d'accumulation pour transporteur a barres
FR2796879B1 (fr)	2001-10-05	Procede pour le recyclage de bandes magnetiques par extrusion
FR2788709B1 (fr)	2001-02-23	Procede pour alimenter un creuset a levitation
FR2794560B1 (fr)	2001-09-21	Procede d'aide a la lecture notamment pour malvoyant
FR2797151B1 (fr)	2002-04-05	Procede pour detruire les taupes
FR2728245B1 (fr)	1999-02-05	Conteneur reutilisable pour produits deshydrates.
FR2703615B1 (fr)	1995-06-16	Procede pour souder des cloches.
FR2776999B3 (fr)	2000-05-26	Procede pour la preparation de 2-chloro-1-cyclohexyl-4- ethynylbenzene